SERA PROGNOSTICS, INC. — Investor Relations & Filings
Sera Prognostics, Inc., also known as 'The Pregnancy Company®', is a health diagnostics company focused on improving maternal and infant health through precision pregnancy care. The company's flagship product is the PreTRM® Test, a first-of-its-kind biomarker blood test designed to predict the individual risk of spontaneous preterm birth in asymptomatic women with singleton pregnancies. The test is administered via a single blood draw during the 18th to 20th week of gestation, providing pivotal information to physicians for proactive management. Sera Prognostics also offers the LikeMine™ platform, which uses data from millions of pregnancies to offer comparative insights. The company aims to deliver high-value diagnostics to providers, mothers, payers, and employers to improve health outcomes and reduce healthcare costs associated with premature birth.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - SERA PROGNOSTICS, INC. (0001534969) (Filer) | 2026-05-06 | English | |
| 10-K - SERA PROGNOSTICS, INC. (0001534969) (Filer) | 2026-03-18 | English | |
| 4 - SERA PROGNOSTICS, INC. (0001534969) (Filer) | 2026-02-25 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-01-27 | English | |
| SCHEDULE 13G/A Filing | 2026-01-16 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 42001700 | 10-Q - SERA PROGNOSTICS, INC. (0001534969) (Filer) | 2026-05-06 | English | ||
| 32979141 | 10-K - SERA PROGNOSTICS, INC. (0001534969) (Filer) | 2026-03-18 | English | ||
| 32893540 | 4 - SERA PROGNOSTICS, INC. (0001534969) (Filer) | 2026-02-25 | English | ||
| 30446374 | 4 Filing | 2026-02-04 | English | ||
| 30446388 | 4 Filing | 2026-01-27 | English | ||
| 30446387 | SCHEDULE 13G/A Filing | 2026-01-16 | English | ||
| 12519022 | 8-K | 2026-01-08 | English | ||
| 12519025 | 8-K | 2026-01-07 | English | ||
|
2025
7 filings
| |||||
| 12519023 | 4 | 2025-12-31 | English | ||
| 12519024 | Regulatory Filings 2025 | 2025-12-30 | English | ||
| 12519026 | 4 | 2025-12-12 | English | ||
| 12519028 | 4 | 2025-12-12 | English | ||
| 12519032 | 4 | 2025-12-12 | English | ||
| 12519029 | 4 | 2025-12-12 | English | ||
| 12519033 | 4 | 2025-12-12 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
SERA PROGNOSTICS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34084/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34084 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34084 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34084 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34084}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SERA PROGNOSTICS, INC. (id: 34084)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.